An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).
Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S.
Donegan CJ, et al. Among authors: hoeh n.
Pilot Feasibility Stud. 2023 Oct 5;9(1):169. doi: 10.1186/s40814-023-01399-8.
Pilot Feasibility Stud. 2023.
PMID: 37798662
Free PMC article.